Z67-33821-93043
2 vaccinations
2 coded responses
24 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 461 / IN
- Registered
- 2021-04-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-01
Registered in v-safe
-
2021-04-01
Dose 1 — Pfizer-BioNTech
- 2021-04-01
-
2021-04-02
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-04-03
- 2021-04-04
-
2021-04-05
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Chills, Headache, Fatigue or tiredness, Nausea, DiarrheaAdult check-in
-
2021-04-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
-
2021-04-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-15
-
2021-04-21
Dose 2 — Pfizer-BioNTech
-
2021-04-21
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
-
2021-04-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-04-25
- 2021-04-26
-
2021-04-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-28
- 2021-05-06
- 2021-05-12
-
2021-05-19
Survey response — day 28, dose 2MedDRA: Migraine — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: MigrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-26
- 2021-06-02
- 2021-07-21
- 2021-10-20
-
2022-04-21
Survey response — 12 months, dose 2MedDRA: Hypothyroidism, Tachycardia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Hypothyroidism; tachycardiaMedDRA releases: 2024-11 · check-in free text available
-
2022-04-21
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
- 2022-04-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech | |
| 2 | 2021-04-21 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-21 | Unsuccessful |
Free text
Release 8 — day 28, dose 2
Symptoms: Migraines
Release 11 — 12 months, dose 2
Symptoms: Hypothyroidism; tachycardia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hypothyroidism | · | · | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Tachycardia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release